Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gavras

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Lancet (London, England)|August 21, 2001
Is ancient Greek a dead language?I Gavras
The New England Journal of Medicine|July 27, 1995
Metaphors and health care reformI Gavras
Kidney International|October 1, 1992
Bradykinin-mediated effects of ACE inhibitionI Gavras
Journal of Clinical Pharmacology|September 1, 1985
Nifedipine in the treatment of essential hypertensionI Gavras, H Gavras
The American Journal of the Medical Sciences|April 1, 1988
Role of bradykinin in hypertension and the antihypertensive effect of angiotensin-converting enzyme inhibitorsI Gavras, H Gavras
Revista Clinica Espanola|March 1, 1987
[Clinical management of hypertension in the elderly]I Gavras, H Gavras
The New England Journal of Medicine|February 25, 1982
Leukopenia: idiopathic or drug-induced?I Gavras, H Gavras
Pharmacotherapy|April 23, 1999
Safety and tolerability of eprosartanI Gavras, H Gavras
Current Medical Research and Opinion|April 27, 1999
Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study GroupI Gavras, H Gavras
Kidney International. Supplement|October 1, 1988
Anti-hormones and blood pressure: bradykinin antagonists in blood pressure regulationI Gavras, H Gavras
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Lancet (London, England)|August 21, 2001
Is ancient Greek a dead language?I Gavras
The New England Journal of Medicine|July 27, 1995
Metaphors and health care reformI Gavras
Kidney International|October 1, 1992
Bradykinin-mediated effects of ACE inhibitionI Gavras
Journal of Clinical Pharmacology|September 1, 1985
Nifedipine in the treatment of essential hypertensionI Gavras, H Gavras
The American Journal of the Medical Sciences|April 1, 1988
Role of bradykinin in hypertension and the antihypertensive effect of angiotensin-converting enzyme inhibitorsI Gavras, H Gavras
Revista Clinica Espanola|March 1, 1987
[Clinical management of hypertension in the elderly]I Gavras, H Gavras
The New England Journal of Medicine|February 25, 1982
Leukopenia: idiopathic or drug-induced?I Gavras, H Gavras
Pharmacotherapy|April 23, 1999
Safety and tolerability of eprosartanI Gavras, H Gavras
Current Medical Research and Opinion|April 27, 1999
Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study GroupI Gavras, H Gavras
Kidney International. Supplement|October 1, 1988
Anti-hormones and blood pressure: bradykinin antagonists in blood pressure regulationI Gavras, H Gavras
Pageof 17